Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21526980
Conclusion of this study
Active tablet formulations were significantly more effective than placebo in protecting volunteers against the development of diarrhea caused by ETEC. These results suggest that administration of a tablet formulation of hyperimmune bovine colostrum containing antibodies against ETEC strains may reduce the risk of travelers' diarrhea.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study